Industry Posters (Non-CE) 

Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage: A Prospective Randomized Trial

Presentation Date/Time: Sunday, March 22 from 3:15 – 3:30 PM
Presented by: Carrie D’Andrea, MS Vice President

Click here to view the poster.

Final Results from a Long-Term Open Label Extension Study (Up to 4 Years): Tolerability of Fenfluramine and Global Functioning of Pediatric and Adult Patients with Dravet or Lennox-Gastaut Syndromes

Presentation Date/Time: Sunday, March 22 from 5:45-6 PM
Presented By: Mercedes Martin, MSN, FNP-C, Medical Lead, Rare Epilepsies, UCB, Inc

Click here to view the poster.

Impact of Telemedicine on Time and Process Measures Associated with Detection and Diagnosis of Alzheimer’s Disease

Presentation Date/Time: Monday, March 23 from 12:30 – 12:45 PM
Presented by: Alissa Christina Butler DNP, APRN, FNP-C

Click here to view the poster.